|
|
 |
 |
 |
 |
 |
 |
|
|
Tun-Hou Lee
 Dr. Tun-Hou Lee is a Professor of Virology at the Harvard School of Public Health, serves on the HAI Faculty Advisory Committee, and has also served as Acting Chairman for HAI (2001).
Most of Dr. Lee’s research relates to human and related primate retroviruses. He has helped to develop serologic testing for the human leukemia virus (HTLV-I) and HIV. Additionally, Dr. Lee first discovered the HTLV-I, HTLV-II and HIV's envelope gene products. He also demonstrated that the envelope antibody is the most important marker for screening individuals for infection with the human retroviruses, a finding, which became the basis for serologic tests in blood bank screening. In Dr. Lee's research on HIV envelope protein, he discovered an association between the progress from HIV to AIDS and certain missing envelope antibodies. He has also examined the immune response to HIV envelope protein, along with the results of HIV infection.
Dr. Lee identified the putative transforming protein of HTLV-I, which was also the first observation of a non-oncogene retrovirus protein linked to a cancer. His recent research examines the modification of the antigenicity of HIV envelope protein. He has also investigated HIV subtype C, and its implications for vaccine development in Africa.
Dr. Lee received his doctorate of science from the Harvard School of Public Health. Author or co-author to over 100 papers, Dr. Lee has also received fellowships from the Swedish Medical Research Council and the Leukemia Society of America.
|
|
|
